FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3108137730> ?p ?o ?g. }

• W3108137730 abstract "Immune checkpoint inhibitors (ICIs) are used widely for treating metastatic urothelial carcinoma (mUC). In practical settings, evidence is lacking on the efficacy of ICIs in some difficult-to-treat patients, such as those with end-stage renal disease (ESRD). Herein, we evaluate the safety and efficacy of ICIs for patients with mUC and ESRD.For this retrospective study, patients with mUC who were given ICIs at Kaohsiung Chang Gang Memorial Hospital and Linkou Chang Gung Memorial Hospital between April 2016 and November 2019 were consecutively enrolled. All clinicopathologic data, treatment responses, and adverse events were recorded. The immune-related adverse events (AEs), objective response rate (ORR), progression-free survival (PFS), and overall survival (OS) were compared between ESRD and non-ESRD groups.In total, 129 patients with mUC were enrolled, with 11 patients categorized as the ESRD group. Among these patients with ESRD receiving ICIs, 7 of 11 (63.6%) had high-grade (grade ≥3) AEs, chiefly hematologic toxicity. Some rarely encountered AEs were noted, including toxic epidermal necrolysis, tuberculosis reactivation, ascites, and cytokine release syndrome. Patients in the ESRD group had numerically higher ORR (54.5% vs. 28.8%, p = 0.09), PFS (7.1 vs. 3.5 months, p = 0.42), and OS (not reached vs. 15.4 months) than the non-ESRD group. A multivariate Cox regression model demonstrated that leukocytosis (hazard ratio [HR]: 2.63; 95% confidence interval [CI]: 1.23-5.63; p = 0.01) and neutrophil-to-lymphocyte ratio (HR 2.91; 95% CI: 1.30-6.53; p = 0.01) were independent prognostic factors.Administration of ICIs in patients with mUC and ESRD demonstrated a modest antitumor activity, and should be used with caution for increasing risk of hematologic toxicity." @default.
• W3108137730 created "2020-12-07" @default.
• W3108137730 creator A5001384627 @default.
• W3108137730 creator A5002765830 @default.
• W3108137730 creator A5020884579 @default.
• W3108137730 creator A5022533478 @default.
• W3108137730 creator A5024859729 @default.
• W3108137730 creator A5035760538 @default.
• W3108137730 creator A5042151733 @default.
• W3108137730 creator A5047715323 @default.
• W3108137730 creator A5069445490 @default.
• W3108137730 creator A5076863688 @default.
• W3108137730 creator A5087276315 @default.
• W3108137730 date "2020-11-27" @default.
• W3108137730 modified "2023-09-24" @default.
• W3108137730 title "Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice" @default.
• W3108137730 cites W1757407923 @default.
• W3108137730 cites W1965260936 @default.
• W3108137730 cites W2054509906 @default.
• W3108137730 cites W2101562875 @default.
• W3108137730 cites W2146904754 @default.
• W3108137730 cites W2223436478 @default.
• W3108137730 cites W2289712604 @default.
• W3108137730 cites W2295766629 @default.
• W3108137730 cites W2300181798 @default.
• W3108137730 cites W2303235652 @default.
• W3108137730 cites W2434614187 @default.
• W3108137730 cites W2510565493 @default.
• W3108137730 cites W2521230355 @default.
• W3108137730 cites W2529221862 @default.
• W3108137730 cites W2559804019 @default.
• W3108137730 cites W2560460441 @default.
• W3108137730 cites W2572174216 @default.
• W3108137730 cites W2582671354 @default.
• W3108137730 cites W2588916311 @default.
• W3108137730 cites W2599150633 @default.
• W3108137730 cites W2604441970 @default.
• W3108137730 cites W2620163654 @default.
• W3108137730 cites W2736402482 @default.
• W3108137730 cites W2750116245 @default.
• W3108137730 cites W2761661900 @default.
• W3108137730 cites W2768465438 @default.
• W3108137730 cites W2802155618 @default.
• W3108137730 cites W2807876762 @default.
• W3108137730 cites W2808166290 @default.
• W3108137730 cites W2809417568 @default.
• W3108137730 cites W2897541686 @default.
• W3108137730 cites W2902613274 @default.
• W3108137730 cites W2910182806 @default.
• W3108137730 cites W2911404554 @default.
• W3108137730 cites W2914899410 @default.
• W3108137730 cites W2919428266 @default.
• W3108137730 cites W2956566890 @default.
• W3108137730 cites W2987204971 @default.
• W3108137730 cites W2999447726 @default.
• W3108137730 cites W3011105509 @default.
• W3108137730 cites W3024361750 @default.
• W3108137730 doi "https://doi.org/10.3389/fonc.2020.584834" @default.
• W3108137730 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7729012" @default.
• W3108137730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33330066" @default.
• W3108137730 hasPublicationYear "2020" @default.
• W3108137730 type Work @default.
• W3108137730 sameAs 3108137730 @default.
• W3108137730 citedByCount "10" @default.
• W3108137730 countsByYear W31081377302021 @default.
• W3108137730 countsByYear W31081377302022 @default.
• W3108137730 countsByYear W31081377302023 @default.
• W3108137730 crossrefType "journal-article" @default.
• W3108137730 hasAuthorship W3108137730A5001384627 @default.
• W3108137730 hasAuthorship W3108137730A5002765830 @default.
• W3108137730 hasAuthorship W3108137730A5020884579 @default.
• W3108137730 hasAuthorship W3108137730A5022533478 @default.
• W3108137730 hasAuthorship W3108137730A5024859729 @default.
• W3108137730 hasAuthorship W3108137730A5035760538 @default.
• W3108137730 hasAuthorship W3108137730A5042151733 @default.
• W3108137730 hasAuthorship W3108137730A5047715323 @default.
• W3108137730 hasAuthorship W3108137730A5069445490 @default.
• W3108137730 hasAuthorship W3108137730A5076863688 @default.
• W3108137730 hasAuthorship W3108137730A5087276315 @default.
• W3108137730 hasBestOaLocation W31081377301 @default.
• W3108137730 hasConcept C126322002 @default.
• W3108137730 hasConcept C143998085 @default.
• W3108137730 hasConcept C197934379 @default.
• W3108137730 hasConcept C207103383 @default.
• W3108137730 hasConcept C2777472916 @default.
• W3108137730 hasConcept C2779134260 @default.
• W3108137730 hasConcept C3019040382 @default.
• W3108137730 hasConcept C44249647 @default.
• W3108137730 hasConcept C71924100 @default.
• W3108137730 hasConcept C90924648 @default.
• W3108137730 hasConceptScore W3108137730C126322002 @default.
• W3108137730 hasConceptScore W3108137730C143998085 @default.
• W3108137730 hasConceptScore W3108137730C197934379 @default.
• W3108137730 hasConceptScore W3108137730C207103383 @default.
• W3108137730 hasConceptScore W3108137730C2777472916 @default.
• W3108137730 hasConceptScore W3108137730C2779134260 @default.
• W3108137730 hasConceptScore W3108137730C3019040382 @default.
• W3108137730 hasConceptScore W3108137730C44249647 @default.
• W3108137730 hasConceptScore W3108137730C71924100 @default.
• W3108137730 hasConceptScore W3108137730C90924648 @default.

• next